Patrick Langlois

Président chez ArkAb SAS

Profil

Patrick J.
Langlois is currently Chairman at ArkAb SAS since 2018, General Partner at PJL Consulting since 2005, and General Partner at DFC Langlois.
Former roles include Non-Executive Chairman at Stallergenes SAS from 2011 to 2015, Chairman at Valerio Therapeutics SA from 2011 to 2016, Vice Chairman-Supervisory Board at Exonhit, Independent Chairman at Sensorion SA from 2015 to 2020, Chairman at B Cell Design SAS, Vice Chairman-Supervisory Board at Eurobio-Scientific SA from 2012 to 2014, Vice Chairman at Stallergenes Greer Ltd., Director at Shire Plc from 2005 to 2008, Director at Coley Pharmaceutical Group, Inc., Non-Executive Director at Shire Acquisition, Inc., Director at Shire Plc from 2005 to 2009, Independent Director at SCYNEXIS, Inc., Director at Curium PET France, Independent Non-Executive Director at Newron Pharmaceuticals SpA from 2008 to 2026, Chief Financial Officer & Group Executive VP at Aventis SA from 1999 to 2004, Chief Financial Officer at Rhone-Poulenc Rorer, Inc. in 1999, Independent Member-Supervisory Board at Innate Pharma SA from 2010 to 2022, President at DrugAbuse Sciences SAS, and President at Nanobiotix SA. Education includes a doctorate and undergraduate degree from the University of Rennes.

Postes actifs de Patrick Langlois

Sociétés	Poste	Début
PJL Consulting	Corporate Officer/Principal	01/02/2005
DFC Langlois	Corporate Officer/Principal	-
ArkAb SAS	Président	13/01/2018

Anciens postes connus de Patrick Langlois

Sociétés	Poste	Fin
NEWRON PHARMACEUTICALS S.P.A.	Directeur/Membre du Conseil	23/04/2026
INNATE PHARMA	Directeur/Membre du Conseil	20/05/2022
B Cell Design SAS	Président	01/01/2021
SENSORION	Président	05/07/2020
STALLERGENES GREER	Directeur/Membre du Conseil	07/06/2018